Last reviewed · How we verify
NCT05808530
Cognitive Stimulation Therapy
NA trial testing Cognitive Stimulation Therapy in Alzheimer Disease 10 in 56 participants. Completed in 30 December 2023.
30 October 2023
Quick facts
| Lead sponsor | Hasan Kalyoncu University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | supportive care |
| Enrollment | 56 |
| Start date | 1 May 2023 |
| Primary completion | 30 October 2023 |
| Estimated completion | 30 December 2023 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Cognitive Stimulation Therapy
Conditions studied
- Alzheimer Disease 10 — all drugs for Alzheimer Disease 10 →
- Dementia — all drugs for Dementia →
- Apathy — all drugs for Apathy →
- Anxiety — all drugs for Anxiety →
Sponsor
Hasan Kalyoncu University
Who can join
60 and older, any sex, with Alzheimer Disease 10 or Dementia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The concept of cognitive stimulation in AD is one of the most popular approaches. Cognitive Stimulation Therapy (CST) is stated to be evidence-based best practice with robust clinical trials, administered according to specific guidelines for individuals with mild to moderate dementia. In this study, it was aimed to investigate the effects of CST application on the levels of apathy, loneliness, anxiety and daily living activities in elderly individuals with Alzheimer's disease. This research was planned in an experimental research design with a single center and pretest posttest control group. The research was planned to be carried out between January 2023 and June 202 at the Moral House of Gaziantep Metropolitan Municipality, Department of Disabled and Health Services. Introductory Information Form, Standardized Mini-Mental Test, Geriatric Anxiety Scale, Apathy Rating Scale, Loneliness Scale and Functional Disability in Dementia Scale will be used in the research. CST will be administered by a researcher trained in therapy, 2 days a week, for a total of 14 sessions of 45-50 minutes. There will be a pre-test before the application, an intermediate test right after the application, and a post-test three months later. Research data will be evaluated in SPSS 25.0 New York package program.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05808530
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Cognitive Stimulation Therapy
Trials testing the same drug.
- NCT06978972 — Cognitive Stimulation Therapy for Residents With Dementia in Nursing Homes · NA · completed
- NCT06115785 — Cognitive Stimulation Therapy and Olderly People With Mild Cognitive Impairment · NA · completed
- NCT05514678 — Cognitive Stimulation Therapy for Dementia · NA · completed
- NCT04754932 — Implementation of Cognitive Stimulation Therapy · NA · completed
- NCT05394584 — CST-HK for Cognition and Well-being in People With Dementia · NA · completed
Other Hasan Kalyoncu University trials
Trials by the same sponsor.
- NCT07263724 — Determining the Consistency Between Nurses and Artificial Intelligence (ChatGPT-5) in Delivering Scenario-Based Discharg · not yet recruiting
- NCT07503678 — CABG-AI-Supported Discharge Education · NA · not yet recruiting
- NCT07429084 — The Clinical Decision-Making Skills of Operating Room Nurses Regarding Knowledge of Inadvertent Perioperative Hypothermi · not yet recruiting
- NCT07493083 — Acute Effects of Posterior Talar Glide Mobilization · NA · not yet recruiting
- NCT07468786 — Masseter Muscle Thickness in Individuals With Chronic Neck Pain · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05808530 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hasan Kalyoncu University
- Last refreshed: 15 March 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05808530.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing